GUANGZHOU PHAR<00874> - Unusual price & volume movements

The Stock Exchange has received a message from Guangzhou Pharmaceutical 
Company Limited which is reproduced as follows:-

"This statement is made at the request of The Stock Exchange of Hong Kong 
Limited.

The board of directors (the "Director") have noted the recent increase in 
the price of the shares and increase of trading volume of the shares of 
Guangzhou Pharmaceutical Company Limited (the "Company") and wish to state 
that the Directors are not aware of any reasons for such increase.

Save as the announcement issued by the Company regarding the continuing 
connected transaction dated 27 April 2005, the Directors also confirm that 
there are no negotiations or agreements relating to intended acquisitions 
or realisations which are Discloseable under Rule 13.23, neither is the 
board of directors (the "Board") aware of any matter Discloseable under 
the general obligation imposed by Rule 13.09, which is or may be of a 
price-sensitive nature.

The Directors collectively and individually accept responsibility for the 
accuracy of this announcement.
 

By order of the Board
Guangzhou Pharmaceutical Company Limited

He Shuhua
Company Secretary

Guangzhou, the People's Republic of China, 28 April 2005

As at the date of this announcement, the Board comprises Mr. Yang 
Rongming, Mr. Zhou Yuejin, and Mr. Feng Zansheng as executive Directors, 
and Mr. Wu Zhang, Mr. Wong Hin Wing and Mr. Zhang Heyong as independent 
non-executive Directors."